XML 96 R59.htm IDEA: XBRL DOCUMENT
v2.4.1.9

Discontinued Operations (Details) (USD $) | 3 Months Ended | 12 Months Ended | 0 Months Ended
--- | --- | --- | ---
Dec. 31, 2014 | Sep. 30, 2014 | Jun. 30, 2014 | Mar. 31, 2014 | Dec. 31, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | Jan. 15, 2015
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cash proceeds from divestitures, net |  |  |  |  |  |  |  |  |  |  |  |  | $ 7,700,000 us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested | $ 104,718,000 us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested | $ 0 us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested | $ 9,646,000 us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested |
(Loss) income from discontinued operations (net of tax) | (1,058,000)us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax | [1] | (6,679,000)us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax | [1] | (60,025,000)us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax | [1] | (1,769,000)us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax | [1] | (886,000)us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax | 531,000 us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax | 2,628,000 us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax | 1,835,000 us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax |  | (69,531,000)us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax | 4,108,000 us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax | 4,281,000 us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax |
Loss on disposal of businesses |  |  |  |  |  |  |  |  |  |  |  |  |  | 85,515,000 us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges | 0 us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges | 0 us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges |
Antioxidant, Ibuprofen and Propofol Assets - Discontinued Operations |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cash proceeds from divestitures, net |  |  |  |  |  |  |  |  |  |  |  |  |  | 104,700,000 us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested / us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis = alb_AntioxidantIbuprofenandPropofolAssetsMember |  |  |
Net sales |  |  |  |  |  |  |  |  |  |  |  |  |  | 154,273,000 us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue / us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis = alb_AntioxidantIbuprofenandPropofolAssetsMember | 222,146,000 us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue / us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis = alb_AntioxidantIbuprofenandPropofolAssetsMember | 226,266,000 us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue / us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis = alb_AntioxidantIbuprofenandPropofolAssetsMember |
(Loss) income from discontinued operations |  |  |  |  |  |  |  |  |  |  |  |  |  | (90,439,000)us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax / us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis = alb_AntioxidantIbuprofenandPropofolAssetsMember | 5,985,000 us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax / us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis = alb_AntioxidantIbuprofenandPropofolAssetsMember | 6,381,000 us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax / us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis = alb_AntioxidantIbuprofenandPropofolAssetsMember |
Income tax (benefit) expense |  |  |  |  |  |  |  |  |  |  |  |  |  | (20,908,000)us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation / us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis = alb_AntioxidantIbuprofenandPropofolAssetsMember | 1,877,000 us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation / us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis = alb_AntioxidantIbuprofenandPropofolAssetsMember | 2,100,000 us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation / us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis = alb_AntioxidantIbuprofenandPropofolAssetsMember |
(Loss) income from discontinued operations (net of tax) |  |  |  |  |  |  |  |  |  |  |  |  |  | (69,531,000)us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax / us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis = alb_AntioxidantIbuprofenandPropofolAssetsMember | 4,108,000 us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax / us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis = alb_AntioxidantIbuprofenandPropofolAssetsMember | 4,281,000 us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax / us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis = alb_AntioxidantIbuprofenandPropofolAssetsMember |
Loss on disposal of businesses |  |  |  |  |  |  |  |  |  |  |  |  |  | 85,500,000 us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges / us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis = alb_AntioxidantIbuprofenandPropofolAssetsMember |  |  |
Loss on disposal of businesses, net of tax |  |  |  |  |  |  |  |  |  |  |  |  |  | 65,700,000 alb_GainLossonSaleofAssetsandAssetImpairmentChargesnetoftax / us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis = alb_AntioxidantIbuprofenandPropofolAssetsMember |  |  |
Cumulative foreign currency translation gains included in pre-tax impairment charge |  |  |  |  |  |  |  |  |  |  |  |  |  | 17,800,000 us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses / us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis = alb_AntioxidantIbuprofenandPropofolAssetsMember |  |  |
Discontinued Operations | Antioxidant, Ibuprofen and Propofol Assets - Discontinued Operations |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Post-closing adjustment, cash received |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 7,600,000 us-gaap_ProceedsFromDivestitureOfBusinesses / us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis = alb_AntioxidantIbuprofenandPropofolAssetsMember / us-gaap_SubsequentEventTypeAxis = us-gaap_SegmentDiscontinuedOperationsMember
[1] | Included in Loss from discontinued operations (net of tax) for the year ended December 31, 2014 is $(65.7) million related to the loss on the sale of our antioxidant, ibuprofen and propofol businesses and assets, the majority of which was recorded in the second quarter. See Note 2, “Discontinued Operations.”

X
- Definition Amount of gain (loss) from the difference between the sale price or salvage price and the book value of an asset that was sold or retired, and gain (loss) from the write down of assets from their carrying value to fair value, net of tax. + References No definition available. + Details
Name: | alb_GainLossonSaleofAssetsandAssetImpairmentChargesnetoftax
Namespace Prefix: | alb_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Overall income (loss) from a disposal group that is classified as a component of the entity, before income tax, reported as a separate component of income before extraordinary items. Includes the following (before income tax): income (loss) from operations during the phase-out period, gain (loss) on disposal, provision (or any reversals of earlier provisions) for loss on disposal, and adjustments of a prior period gain (loss) on disposal. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1361-107760 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 45 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e957-107759 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.12) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 13 -Article 7 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 05 -Paragraph 15 -Article 3 + Details
Name: | us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Tax effect allocated to a disposal group that is classified as a component of the entity reported as a separate component of income before extraordinary items. Includes the tax effects of the following: income (loss) from operations during the phase-out period, gain (loss) on disposal, provision (or any reversals of earlier provisions) for loss on disposal, and adjustments of a prior period gain (loss) on disposal. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (b),(c) -URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1361-107760 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32672-109319 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 20 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=18498875&loc=d3e38679-109324 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 45 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e957-107759 + Details
Name: | us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of foreign currency translation gains or losses included in the disposal group, whether or not a component of the entity (discontinued operation), that were previously reported in accumulated other comprehensive Income or Loss. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 830 -SubTopic 30 -Section 45 -Paragraph 20 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=6915805&loc=d3e32211-110900 + Details
Name: | us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of sales or other form of revenues attributable to the disposal group, including a component of the entity (discontinued operation), during the reporting period. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1361-107760 + Details
Name: | us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of gain (loss) from the difference between the sale price or salvage price and the book value of an asset that was sold or retired, and gain (loss) from the write down of assets from their carrying value to fair value. + References No definition available. + Details
Name: | us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of income (loss) from a disposal group, net of income tax before extraordinary items allocable to noncontrolling interests. Includes, net of tax, income (loss) from operations during the phase-out period, gain (loss) on disposal, provision (or any reversals of earlier provisions) for loss on disposal, and adjustments of a prior period gain (loss) on disposal. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 45 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e957-107759 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.12) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 13 -Article 7 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1361-107760 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.14) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 15 -Article 5 + Details
Name: | us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Investing Activities -URI http://asc.fasb.org/extlink&oid=6516133 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 12 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3179-108585 + Details
Name: | us-gaap_ProceedsFromDivestitureOfBusinesses
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition This element represents the cash inflow during the period from the sale of a component of the entity. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Investing Activities -URI http://asc.fasb.org/extlink&oid=6516133 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 12 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3179-108585 + Details
Name: | us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=alb_AntioxidantIbuprofenandPropofolAssetsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsequentEventTypeAxis=us-gaap_SegmentDiscontinuedOperationsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |